Two recently published clinical data sets of human stomach cancers from The Cancer Genome Atlas (TCGA)20,21 revealed the presence of MYD88 gene deletions and mutations in gastric and esophageal adenocarcinomas. Here, MYD88 is linked to gastric neoplasm.